These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37102219)

  • 1. The clinical benefit of a multimodal topical approach to treating skin dyspigmentation.
    Draelos ZD; Diaz I
    J Cosmet Dermatol; 2023 Jun; 22(6):1799-1804. PubMed ID: 37102219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brightening and Improvement of Facial Skin Quality in Healthy Female Subjects With Moderate Hyperpigmentation or Dark Spots and Moderate Facial Aging.
    Serra M; Bohnert K; Narda M; Granger C; Sadick N
    J Drugs Dermatol; 2018 Dec; 17(12):1310-1315. PubMed ID: 30586263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a Tranexamic Acid, Kojic Acid, and Niacinamide Containing Serum on Facial Dyschromia: A Clinical Evaluation.
    Desai S; Ayres E; Bak H; Manco M; Lynch S; Raab S; Du A; Green D; Skobowiat C; Wangari-Talbot J; Zheng Q
    J Drugs Dermatol; 2019 May; 18(5):454-459. PubMed ID: 31141852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the Safety and Efficacy of a Topical Formulation Containing Epidermal Growth Factor, Tranexamic Acid, Vitamin C, Arbutin, Niacinamide and Other Ingredients as Hydroquinone 4% Alternatives to Improve Hyperpigmentation: A Prospective, Randomized, Controlled Split Face Study.
    Kalasho BD; Minokadeh A; Zhang-Nunes S; Zoumalan RA; Shemirani NL; Waldman AR; Pletzer V; Zoumalan CI
    J Cosmet Sci; 2020; 71(5):263-290. PubMed ID: 33022197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction in facial hyperpigmentation after treatment with a combination of topical niacinamide and tranexamic acid: a randomized, double-blind, vehicle-controlled trial.
    Lee DH; Oh IY; Koo KT; Suk JM; Jung SW; Park JO; Kim BJ; Choi YM
    Skin Res Technol; 2014 May; 20(2):208-12. PubMed ID: 24033822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An effective hydroquinone alternative for topical skin lightening.
    Draelos ZD; Deliencourt-Godefroy G; Lopes L
    J Cosmet Dermatol; 2020 Dec; 19(12):3258-3261. PubMed ID: 33098161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of a depigmenting gel serum comprising tranexamic acid, niacinamide, 4-butylresorcinol, phytic acid, and a mixture of hydroxy acids that targets the biological processes regulating skin melanogenesis.
    Furmanczyk M; Brown A; Bustos J; de Henestrosa ARF; Trullas C; Granger C; Jourdan E
    J Cosmet Dermatol; 2024 Jun; 23(6):2058-2065. PubMed ID: 38549196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a hydroquinone-free skin brightening product using in vitro inhibition of melanogenesis and clinical reduction of ultraviolet-induced hyperpigmentation.
    Makino ET; Mehta RC; Banga A; Jain P; Sigler ML; Sonti S
    J Drugs Dermatol; 2013 Mar; 12(3):s16-20. PubMed ID: 23545928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A split-face evaluation of a novel pigment-lightening agent compared with no treatment and hydroquinone.
    Draelos ZD
    J Am Acad Dermatol; 2015 Jan; 72(1):105-7. PubMed ID: 25440437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dyspigmentation, skin physiology, and a novel approach to skin lightening.
    Draelos Z; Dahl A; Yatskayer M; Chen N; Krol Y; Oresajo C
    J Cosmet Dermatol; 2013 Dec; 12(4):247-53. PubMed ID: 24305422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of a novel multimodality hydroquinone-free skin brightener over six months.
    Bruce S
    J Drugs Dermatol; 2013 Mar; 12(3):S27-31. PubMed ID: 23545930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of In-Office Chemical Peels With a Topical Comprehensive Pigmentation Control Product in Skin of Color Subjects With Facial Hyperpigmentation.
    Downie J; Schneider K; Goberdhan L; Makino ET; Mehta RC
    J Drugs Dermatol; 2017 Apr; 16(4):301-306. PubMed ID: 28403262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Randomized, Investigator-Blinded Comparison of Two Topical Regimens in Fitzpatrick Skin Types III-VI With Moderate to Severe Facial Hyperpigmentation.
    Vanaman Wilson MJ; Jones IT; Bolton J; Larsen L; Wu DC; Goldman MP
    J Drugs Dermatol; 2017 Nov; 16(11):1127-1132. PubMed ID: 29141061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An open-label, investigator-initiated, single-center, prospective, pilot clinical study to evaluate the efficacy of a skin whitening serum applied twice daily combined with a spot-preventing SPF50+ sunscreen in healthy female subjects with melasma hyperpigmentation.
    Cantelli M; Ferrillo M; Granger C; Fabbrocini G
    J Cosmet Dermatol; 2022 Apr; 21(4):1523-1532. PubMed ID: 34087055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of hydroquinone-free and hydroquinone-based hyperpigmentation regimens in treating facial hyperpigmentation and photoaging.
    Fabi SG; Goldman MP
    J Drugs Dermatol; 2013 Mar; 12(3):S32-7. PubMed ID: 23545931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of two commercial hyperpigmentation kits in the treatment of facial hyperpigmentation and photo-aging.
    Fabi S; Massaki N; Goldman MP
    J Drugs Dermatol; 2012 Aug; 11(8):964-8. PubMed ID: 22859242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Facial Treatment Regimen Improves Aging Skin Appearance.
    Farris P; Draelos ZD; Felipe de Oliveira Stehling L
    J Drugs Dermatol; 2021 Mar; 20(3):274-278. PubMed ID: 33683078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound enhanced skin-lightening effect of vitamin C and niacinamide.
    Hakozaki T; Takiwaki H; Miyamoto K; Sato Y; Arase S
    Skin Res Technol; 2006 May; 12(2):105-13. PubMed ID: 16626384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction in the appearance of facial hyperpigmentation after use of moisturizers with a combination of topical niacinamide and N-acetyl glucosamine: results of a randomized, double-blind, vehicle-controlled trial.
    Kimball AB; Kaczvinsky JR; Li J; Robinson LR; Matts PJ; Berge CA; Miyamoto K; Bissett DL
    Br J Dermatol; 2010 Feb; 162(2):435-41. PubMed ID: 19845667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating the efficacy of a fractionated 1927 nm laser for diffuse dyspigmentation and actinic changes.
    Vingan NR; Panton JA; Barillas J; Lazzarini A; Hoopman J; Kenkel JM; Culver A
    Lasers Surg Med; 2023 Apr; 55(4):344-358. PubMed ID: 36950878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.